Cross-institution positioning
Aug 12, 2026Mixed positioning. No institution has two comparable Schedule 13 observations yet.
Source: Schedule 13 researchArxis, Inc.
Latest stored close $46.77 as of Oct 8, 2026 View live quote ↗
See how each tracked institution's reported ownership changed across SEC position dates. Full history is available with Investor or Pro access.
What the evidence shows across the newest institutional, insider, company-event, 13F, fundamental, and price data; STOCKNODE combines these layers into a quantitative research signal while preserving each source and reporting window.
Mixed positioning. No institution has two comparable Schedule 13 observations yet.
Source: Schedule 13 researchRecent Forms 3/4/5 activity is available, with no non-amendment non-derivative SEC-coded P/S transactions in the rolling 90-day window. Amendments are shown in the filing evidence but excluded from rolling activity totals.
Source: SEC Forms 3/4/52 non-amendment material events in the last 90 days; 1 capital-related filing/event (1 equity-related, 0 debt-related); Latest classified evidence: Acquisition or disposition of assets. Registration and prospectus filings are treated as financing capacity/disclosure evidence, not proof that securities were sold.
Source: SEC 8-K / securities filing metadataRevenue +25.0% YoY; Net income +83.2% YoY. Periods are compared only when the SEC facts are aligned and comparable.
Source: SEC Company FactsRecent close is 58% through its reported 52-week range.
Source: Stored historical price seriesFiled Aug 12, 2026. Unlock the dated position comparison, disclosure classification, confidence, price context, and filing-specific significance analysis.
Premium research values are withheld until unlocked.
The research summary above gives the current read. This section shows the dated holder-level evidence behind it.
See each institution's newest reported position against its own prior report, with position as-of date separated from SEC filed date. Institution names and filing freshness remain public below.
Comparable holder direction grouped by SEC position as-of date — never presented as trade dates.
Compare each institution only with its own prior reported position. Public visitors can see who is tracked and how fresh the filing is; paid research reveals the actual comparison.
Investor and Pro reveal holder-by-holder changes, reported ownership history, dated breadth, disclosure timing, institution comparison, and filing-specific analysis without treating Schedule 13 reports as trade dates.
Reported Section 16 ownership activity. Rolling purchase/sale totals use non-derivative SEC transaction codes P and S only; amendments remain visible but are excluded from those totals.
| Date | Reporting owner | Code | Security | Shares | Price | Ownership | Filed |
|---|---|---|---|---|---|---|---|
| Aug 19, 2026 | Roth Jason Aaron | AGrant, award, or other acquisition | Class A Common Stock | 34.1K | $0.00 | Direct | Aug 21, 2026 |
| Apr 17, 2026 | Jankowski Ryan Anthony | POpen-market or private purchase | Class A Common Stock | 4.5K | $28.00 | Direct | Apr 20, 2026 |
| Apr 17, 2026 | Badakhsh Azad Sid | POpen-market or private purchase | Class A Common Stock | 36.0K | $28.00 | Direct | Apr 20, 2026 |
| Apr 17, 2026 | Sealfon Ross Bradley | POpen-market or private purchase | Class A Common Stock | 12.5K | $28.00 | Direct | Apr 20, 2026 |
| Apr 17, 2026 | Oetgen Stephen Duane | POpen-market or private purchase | Class A Common Stock | 25.0K | $28.00 | Direct | Apr 20, 2026 |
| Apr 17, 2026 | Oetgen Stephen Duane | AGrant, award, or other acquisition | Class A Common Stock | 5.4K | $0.00 | Direct | Apr 20, 2026 |
| Apr 17, 2026 | ALLEN PATRICK E | POpen-market or private purchase | Class A Common Stock | 10.0K | $28.00 | Direct | Apr 20, 2026 |
| Apr 17, 2026 | ALLEN PATRICK E | AGrant, award, or other acquisition | Class A Common Stock | 5.4K | $0.00 | Direct | Apr 20, 2026 |
| Apr 17, 2026 | Perhamus Kevin Scott | POpen-market or private purchase | Class A Common Stock | 53.6K | $28.00 | Direct | Apr 20, 2026 |
| Apr 17, 2026 | Roth Jason Aaron | POpen-market or private purchase | Class A Common Stock | 60.0K | $28.00 | Direct | Apr 20, 2026 |
| Apr 16, 2026 | Jankowski Ryan Anthony | AGrant, award, or other acquisition | Class A Common Stock | 46.9K | — | Direct | Apr 20, 2026 |
| Apr 16, 2026 | Allen Jennifer H. | AGrant, award, or other acquisition | Class A Common Stock | 53.7K | — | Direct | Apr 20, 2026 |
| Apr 16, 2026 | Badakhsh Azad Sid | AGrant, award, or other acquisition | Class A Common Stock | 367.9K | — | Direct | Apr 20, 2026 |
| Apr 16, 2026 | Sealfon Ross Bradley | AGrant, award, or other acquisition | Class A Common Stock | 1.1M | — | Direct | Apr 20, 2026 |
| Apr 16, 2026 | Perhamus Kevin Scott | AGrant, award, or other acquisition | Class A Common Stock | 3.5M | — | Direct | Apr 20, 2026 |
| Apr 16, 2026 | Roth Jason Aaron | AGrant, award, or other acquisition | Class A Common Stock | 335.5K | — | Direct | Apr 20, 2026 |
| Apr 16, 2026 | Arcline Double Eagle Master Fund-A LP, Engineered Components Borrower Series LP - Engineered Polymer Series, Engineered Components Borrower Series LP - Hawkeye Series, Engineered Components Borrower Series LP - Ovation Series, Engineered Components Borrower Series LP - Connector Series, Amara Rajeev, Ravindran Shyam | AGrant, award, or other acquisition · derivative | Class B Common Stock | 340.7M | — | Direct | Apr 20, 2026 |
| Apr 16, 2026 | Arcline Double Eagle Master Fund-A LP, Engineered Components Borrower Series LP - Engineered Polymer Series, Engineered Components Borrower Series LP - Hawkeye Series, Engineered Components Borrower Series LP - Ovation Series, Engineered Components Borrower Series LP - Connector Series, Amara Rajeev, Ravindran Shyam | AGrant, award, or other acquisition | Convertible Common Stock | 1 | $0.00 | Indirect | Apr 20, 2026 |
Recent 8-K item classifications plus securities registration and prospectus filings. Registration or prospectus filings show financing capacity/disclosure activity; they do not by themselves prove that securities were sold.
| Filed | Form | 8-K item(s) | Classification | Capital context | SEC |
|---|---|---|---|---|---|
| Aug 18, 2026 | 8-K | 2.01, 3.02, 9.01 | Acquisition or disposition of assets; Unregistered sale of equity securities; Financial statements / exhibits | Equity | Filing |
| Jul 29, 2026 | 8-K | 2.02, 9.01 | Results of operations / financial condition; Financial statements / exhibits | — | Filing |
| Jun 2, 2026 | 8-K | 1.01, 8.01, 9.01 | Material definitive agreement; Other event; Financial statements / exhibits | — | Filing |
| May 28, 2026 | 8-K | 2.02, 9.01 | Results of operations / financial condition; Financial statements / exhibits | — | Filing |
Period-aligned SEC facts. Comparisons appear only when periods and units are comparable.
| Period | Revenue | YoY |
|---|---|---|
| Ended Jun 30, 2026 | $500.7M | +25.0% |
| Ended Jun 30, 2025 | $400.4M | — |
Dated price context from the historical market series already collected for this security.
Returns are close-to-close price changes. Volatility and drawdown are factual historical context, not recommendations.
Schedule 13G/13D reports beneficial ownership at an observation date. “Accumulation” or “reduction” is inferred from changes in reported shares when available; it is not a list of individual trades or exact execution prices.
Form 13F rows are quarter-end holding context only and do not establish an exact entry date.
For more context, see how to read a Schedule 13G, filing date vs event date, or Schedule 13G vs Schedule 13D.
| Holder | Observed / filed | Reported change | Shares | Ownership | Observation | Filing | Latest |
|---|---|---|---|---|---|---|---|
| Capital Research Global Investors CIK0001422848 | Jun 30, 2026 quarter end Aug 12, 2026 filed Form 13F quarter-end evidence | Earlier Form 13F quarter-end holding Quarter-end holding evidence; no ownership percentage or signal. | 3.6M | $46.77 | |||
| Capital Research Global Investors CIK0001422848 | Jun 30, 2026 observed Aug 12, 2026 filed · 43d Initial Schedule 13G | Initial Schedule 13G | 3.6M | 5.20% | $46.14 | $58.10 | $46.77 |
Compare ARXS with other securities showing similar institutional activity or recent accumulation across several tracked institutions.